124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal patient preparation methods
124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal patient preparation methods
- 2015
MedStar Washington Hospital Center
Medicine/Nuclear Medicine
MedStar Washington Hospital Center
Medicine/Nuclear Medicine